SERINO, Maria Luisa
 Distribuzione geografica
Continente #
NA - Nord America 5.038
EU - Europa 2.007
AS - Asia 1.177
SA - Sud America 14
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 3
Totale 8.256
Nazione #
US - Stati Uniti d'America 5.016
IT - Italia 754
CN - Cina 527
UA - Ucraina 335
SG - Singapore 323
DE - Germania 260
TR - Turchia 256
PL - Polonia 163
GB - Regno Unito 147
FI - Finlandia 97
SE - Svezia 96
SM - San Marino 44
ID - Indonesia 30
FR - Francia 28
BE - Belgio 25
CA - Canada 18
CZ - Repubblica Ceca 14
VN - Vietnam 12
BR - Brasile 11
LT - Lituania 9
NL - Olanda 8
RU - Federazione Russa 8
IN - India 7
IR - Iran 7
EG - Egitto 5
IE - Irlanda 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EU - Europa 4
MX - Messico 4
KE - Kenya 3
RO - Romania 3
CH - Svizzera 2
DK - Danimarca 2
ES - Italia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
TH - Thailandia 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
CO - Colombia 1
EC - Ecuador 1
HK - Hong Kong 1
IQ - Iraq 1
JP - Giappone 1
KR - Corea 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
Totale 8.256
Città #
Woodbridge 658
Fairfield 536
Chandler 483
Jacksonville 404
Santa Clara 312
Houston 290
Ann Arbor 261
Ashburn 258
Singapore 254
Seattle 231
Wilmington 224
Warsaw 162
Cambridge 157
Izmir 150
Ferrara 114
Nanjing 112
Beijing 107
Milan 90
Princeton 86
Boardman 71
Shanghai 57
New York 56
San Diego 46
Bremen 38
Shenyang 34
Dearborn 32
Hebei 30
Jakarta 29
Nanchang 26
Brussels 23
Changsha 23
Helsinki 21
Los Angeles 21
Jiaxing 20
Redwood City 20
London 18
Rome 18
Düsseldorf 17
Jinan 15
Mountain View 15
Munich 15
Brno 13
Falls Church 13
Tianjin 13
Bologna 12
Dong Ket 12
Des Moines 11
Meda 11
Guangzhou 10
Kunming 10
Toronto 10
Washington 10
Auburn Hills 9
Frankfurt am Main 9
Napoli 9
Orange 8
Augusta 7
Domagnano 7
Ottawa 7
Ansbach 6
Brescia 6
Changchun 6
Dogana 6
Ningbo 6
Norwalk 6
Pavia 6
Pescara 6
Redmond 6
San Marino 6
Ardabil 5
Duncan 5
Hangzhou 5
Naples 5
Calvisano 4
Ferrara di Monte Baldo 4
Florence 4
Monmouth Junction 4
San Mateo 4
Turin 4
Addison 3
Altopascio 3
Council Bluffs 3
Davoli 3
Hefei 3
Lodi 3
Marino 3
Monticello Conte Otto 3
Padova 3
Sheffield 3
Siracusa 3
Torre del Greco 3
Walnut 3
Zhengzhou 3
Acton 2
Albizzate 2
Auckland 2
Bangalore 2
Cairo 2
Carpi 2
Casoria 2
Totale 5.875
Nome #
ProC Global test>ProC Complete test: una modificazione del Global test per la misurazione contemporanea della attività della PC, della PS, e del fenotipo Leiden. 441
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 221
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in Cognitive Impairment Diseases 172
Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: identification of gender prognostic indicators 169
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 163
Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration 162
Factor XIII contrasts the effects of metalloproteinases in human dermal fibroblast cultured cells 146
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 145
Coagulation factor XIIIA (F13A1): Novel perspectives in treatment and pharmacogenetics 137
Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family. 136
Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension 133
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 132
F13A1 gene variant (V34L) and residual circulating FXIIIA levels predict short-and long-term mortality in acute myocardial infarction after coronary angioplasty 127
A common mutation in the gene for coagulation factor XIII-A (Val34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases 126
Blood Group O Protects against Inhibitor Development in Severe Hemophilia A Patients 126
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease. 124
Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis 121
Different anticoagulant response to activated protein C (APC test) and to Agkistrodon Contortix venom (ACV test) in a family with FV-R506Q substitution 121
COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? 121
A photometric assay for factor-XIII in chronic hepatopathies. 119
null 118
Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories 116
A photometric method for the dosage of factor XIII applied to the study of chronic hepatopathies. 114
The reduced sensitivity of the ProC (R) Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk 112
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy 111
Spectrum of F8 gene mutations in haemophilia A patients from a region of Italy: Identification of 23 new mutations 110
Clinical observations on the relationship between idiopathic thrombocytopenic purpura lupus anticoagulant and anticardio-lipin antibody syndrome. 110
A modified functional Global test to measure protein C, protein S activities and the activated protein C-resistance phenotype. 110
Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers 106
Mortality and causes of death in Italian persons with haemophilia, 1990-2007 105
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 103
Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects 103
null 102
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 99
C677T/A1298C MTHFR Gene Mutations, Homocysteine, Folate Levels and MTHFR Activity, in Normal Subjects and Cases with Myocardial Infarction 97
Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults 96
Center-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation 96
null 91
Una "rete" per proteggere il cuore. (FAR 2013) 90
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 88
Maternal Haplotypes in DHFR Promoter and MTHFR Gene in Tuning Childhood Acute Lymphoblastic Leukemia Onset-Latency: Genetic/Epigenetic Mother/Child Dyad Study (GEMCDS) 88
null 85
C677T Substitution in the Methylenetetrahydrofolate Reductase Gene as a Risk Factor for Venous Thrombosis and Arterial Disease in Selected Patients. 83
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 82
A web-based clinical record 'xl'Emofilia® 'for outpatients with haemophilia and allied disorders in the region of Emilia-Romagna: Features and pilot use 81
null 80
A modified functional Global test to measure PC, PS activities and the APC-Resistance phenotype. 80
Factor XIII-A Gene Mutation (Val34Leu) and Arterial Vascular Disease 79
Common Polymorphisms in the Metabolic Folate Pathway Decrease the Risk of Acute Lymphocytic Leukemia in Adults 78
Caratterizzazione di una nuova mutazione nell’esone 28 del gene del fattore di von Willebrand (FvW) responsabile della malattia di vW di tipo IIA. 76
A de novo antithrombin mutation found in a patient with deep vein thrombosis and vascular abnormalities. 76
Common Polymorphisms in the Metabolic Folate Pathway Decrease the Risk of Acute Lymphocitic Leukemia in Adults 75
Resistance to activated protein C and low levels of protein S activity in nine thrombophilic families: a correct diagnosis. 74
Dihydrofolate reductase (DHFR) 19-bp ins/del polymorphism and methylenetetrahydrofolate reductase (MTHFR) C677T in coronary heart disease patients: potential intracellular folate unbalancing. 74
FXIII Levels in Myocardial Infarction: a Potential Novel Prognostic Biomarker? 74
High protein C plasma levels affect the response to exogenous preactivated protein C and enhance that to endogenous Protac-mediated activated protein C. 72
Effect of factor XIII Val34Leu polymorphism on plasma clot formation: crosslinking functions and clot longevity properties. 72
Anticardiolipin antibody-related thrombocytopenia: persistent remission after splenectomy. 72
Factor V Levels in a Cohort of Patients Eligible for Oral Anticoagulant Therapy. 71
Coexistence of antitrhombin deficency, factor V Leiden and hereditary hyperhomocyst(e)inemia in a thrombotic family. 70
Common Gene Polymorphisms in the Metabolic Folate and Methylation Pathway and the Risk of Acute Lymphoblastic Leukemia and non-Hodgkin’s Lymphoma 69
Thrombotic risk in thalassemic patients. 67
A Common mutation in the gene for coagulation factor XIII-A (V34L): a risk factor for hemorrhagic disorders it is protective against atherothrombotic diseases. 66
Malattie emorragiche vascolari. 64
FXIII-A V34L and FXIII-B H95R gene polymorphism: effects on the efficacy of thrombolytic therapy in acute myocardial infarction. 63
null 61
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 60
Differente risposta alla Proteina C attivata della muatazione R506Q del fattore V della coagulazione (FV Leiden) in due generazioni della stessa famiglia. 59
Low folate levels and thermolabile MTHFR as primary determinant of mild Hyperhomocysteinemia in normal and thromboembolic subjects. 58
Bassi livelli di Proteina S e Resistenza alla Proteina C attivata in dieci famiglie italiane. 57
MTHFR C677T/A1298C, MS A2756G and MTRR A66G Gene Polymorphisms: Effects on Homocysteine Levels and Risk of Miocardial Infarction 55
Low Sensitivity to Endogenous Activated Protein C in Protein S Deficient Subjects Reflects a Reduction in the Thrombotic Risk 54
Detection of a Protein C Gene Mutation Present in the Asymptomatic and not in the Thrombosis-Prone Lineage. 52
Favourable recombinant factor IX pharmacokinetics outcomes in severe hemophilia B patients with FIX activation site mutations 52
Determinazione dell’anticoagulante lupico (LAC) con un metodo al caolino automatizzato. 51
Conteggio piastrinico e terapia sostitutiva in un paziente con Malattia di von Willebrand tipo 2B. 49
null 49
MTHFR Specific Activity, Homocysteine and Folate Levels in Subjects with Thermolabile MTHFR (C677T) 48
Cis-segregation of c.1171c>t stop codon (p.r391*) in serpinc1 gene and c.1691g>a transition (p.r506q) in f5 gene and selected gwas multilocus approach in inherited thrombophilia 47
Sui rapporti tra anticorpi anticardiolipina e ß-2-glicoproteina I plasmatica. 46
Common Factor XIII Gene Polymorphisms In Venous Leg Ulcers. 45
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes 45
Piastrinopenia da anticorpi anticardiolipina: remissione persistente dopo splenectomia. 43
Genotype and PK Hemophilia B International Study (GePKHIS) - A progress Report 42
Host genetics impact on SARS-CoV-2 vaccine-induced immunoglobulin levels and dynamics: The role of TP53, ABO, APOE, ACE2, HLA-A, and CRP genes 41
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 38
Treatment outcome and postoperative complications of mucogingival surgery in a case of type I von Willebrand disease 37
The G to T Point Mutation (Val34Leu) in the Factor XIII-A Subunit Gene in Venous Leg Ulcers 37
Epigenetic role of LINE-1 methylation and key genes in pregnancy maintenance 30
Different anticoagulant response to activated protein C (APC-test) and to Agkistrodon Contortix Venom (ACV-test) in a family with FV-R506Q substitution 30
DHFR 19-bp insertion/deletion polymorphism and MTHFR C677T in adult acute lymphoblastic leukaemia: is the risk reduction due to intracellular folate unbalancing? 25
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 23
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey. 23
GRB 130427A: a Nearby Ordinary Monster 19
miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach 17
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 10
Gene Dosage of F5 c.3481C>T Stop-Codon (p.R1161Ter) Switches the Clinical Phenotype from Severe Thrombosis to Recurrent Haemorrhage: Novel Hypotheses for Readthrough Strategy 1
Totale 8.394
Categoria #
all - tutte 37.467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 289
Totale 37.756


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020880 0 0 0 0 0 194 127 155 110 162 81 51
2020/20211.243 98 103 46 131 97 139 51 140 46 181 151 60
2021/2022837 30 77 46 41 65 36 37 51 28 86 104 236
2022/20231.093 106 104 21 131 189 156 60 109 111 9 63 34
2023/2024605 53 69 26 26 72 94 28 49 9 21 25 133
2024/2025876 72 45 175 91 312 181 0 0 0 0 0 0
Totale 8.394